at-home-diagnostics
(5)
NeoDocs
NeoDocs is a Mumbai health-tech company that turns a smartphone into a diagnostic reader. Users dip a paper test card in a urine sample, scan it with the NeoDocs app, and get lab-referenced results in under a minute - covering kidney, metabolic and general wellness markers. Founded by three IIT Bombay alumni and backed by Y Combinator (S21) and Omidyar Network India, it sells test kits direct to consumers and works with thousands of doctors across India.
Numen
Numen (formerly Cleancard) is a San Francisco biotech building rapid at-home cancer screens that read like a pregnancy test. By combining synthetic biology, machine learning, and computer vision, its platform detects multiple cancer biomarkers from a single urine sample in about 30 minutes, with no lab machinery required. Founded by Rhodes Scholars Thomas Carroll and Luca Springer, the company's first screens target prostate, bladder, and ovarian cancer, with a mission to drive cancer mortality toward zero.
Mira
Mira is a women's health company that built the first at-home hormone monitor with lab-grade accuracy. Its connected device, single-use wands and AI-powered app measure FSH, LH, estrogen (E3G) and PdG so users can map fertility windows, manage PCOS, navigate menopause and share clinical-grade data with their doctors.
Miray Tayfun
Miray Tayfun is the co-founder and CEO of Vivoo, a San Francisco-based health technology company that turns urine test strips into personalized wellness insights via a mobile app. A bioengineering graduate and serial founder, she built Vivoo from a personal frustration with expensive and slow health testing into a platform serving 300,000+ users across 50+ countries. Backed by Tim Draper and $19.4M in total funding, Vivoo expanded from subscription test strips to a $99 smart toilet unveiled at CES 2026, named Best of CES by Gadget Flow. Tayfun is a 2019 Australian Financial Review Top 100 Women of Influence honoree and 2018 Laureate Here for Good Award winner.
Sylvia Kang
Sylvia Kang is the CEO and co-founder of Mira (Miracare), the company behind the world's first FDA and CE-registered comprehensive at-home hormone monitoring platform. A former concert pianist who pivoted to biomedical engineering, she built Mira from her kitchen table into a 140-person company with 200,000+ users worldwide and over 50,000 women helped to conceive naturally. Named to Inc. Magazine's 2024 Female Founders 250 list and Femtech World's Leader of the Year, Kang holds an MS in Biomedical Engineering from Columbia and an MBA from Cornell, and used her own product to conceive after age 35.